Annual report pursuant to Section 13 and 15(d)

Other liabilities

v3.7.0.1
Other liabilities
 12 Months Ended
Jul. 31, 2017
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Other Liabilities Disclosure [Text Block]

Note 9 - Other liabilities


At July 31 Other liabilities consist of:


    2017     2016  
Accrued legal settlement – see Note 14   $ 410     $ 800  
Capital lease obligation     551       794  
Installment loans     22       105  
    $ 983     $ 1,699  

The capital lease obligation and Installment loans are for machinery and equipment used in the Clinical Labs segment. Amortization of the assets recorded under the capital lease is included in depreciation expense. At July 31, 2017, the accumulated amortization on the capital lease was $517 and the imputed interest rate ranges from 4.25% to 9.5%.


Future minimum lease and loan payments are as follows:


  Capital lease     Installment
 loans 		 
2018   $ 209     $ 122  
2019     258       24  
2020     250       —  
2021     165       —  
Total payments     882       146  
Less: interest     (122 )     (2 )
Total net of interest     760       144  
Less: current portion     (209 )     (122 )
Other liabilities - net   $ 551     $ 22  

The weighted average interest rate on our short term borrowings during fiscal 2017 and 2016 was 7.5% and 8.0%, respectively.